Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00827866 · ClinicalTrials.gov registry record · NA
Efficacy of Tobacco Quitline for Cancer Survivors
A NA study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- NA
- Development phase
- 946
- Enrollment target
NCT00827866: Completed NA study, sponsored by St. Jude Children's Research Hospital.
NCT00827866 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 946 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00827866, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 946 participants
- Enrollment target
Study Summary
The proposed study is a two-armed randomized controlled clinical trial examining the long-term (one-year) efficacy of telephone intervention conditions for smoking cessation in a high risk medical population; namely, cancer survivors: Proactive telephone recruitment through the Childhood Cancer Survivors Survey (CCSS) St. Jude Life Study, After Completion of Therapy (ACT) Clinic and face to face recruitment at the local West Clinics will serve as the primary methods of recruitment. The specific aims of the study : (1) To recruit nationally a cohort of approximately 1242 smokers who are cancer survivors(621 childhood cancer survivors and 621 adult cancer survivors); 2) To determine the long-term (one year) efficacy of the intervention condition for participants randomly assigned to the Counselor-initiated versus a Self-paced QL; and (3) to find out whether treatment outcomes vary as a function of survivors' age of cancer diagnosis (survivors who diagnosed while adults vs. childhood cancer survivors who diagnosed before the age of 21).
Interventions
- OTHER Counselor-Initiated Tobacco Quit Line
- OTHER Self-Paced Tobacco Quit Line
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 946 participants |
| Start Date | 2008-10 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT00827866 record still lists
NCT00827866 is an interventional study that assigns participants to a tested intervention. The registered 946 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% lower).
The record links to 0 conditions, and to 2 interventions - of which Counselor-Initiated Tobacco Quit Line is the first listed.
NCT00827866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00827866 about?
NCT00827866 is a clinical study titled "Efficacy of Tobacco Quitline for Cancer Survivors". The proposed study is a two-armed randomized controlled clinical trial examining the long-term (one-year) efficacy of telephone intervention conditions for smoking cessation in a high risk medical population; namely, cancer survivors: Proactive telephone recruitment through the Childhood Cancer Surv...
What is the current status of trial NCT00827866?
This trial is currently completed. It is a NA study. The enrollment target is 946 participants. The study started on 2008-10. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00827866?
The interventions under investigation include: Counselor-Initiated Tobacco Quit Line (OTHER), Self-Paced Tobacco Quit Line (OTHER).
Who is sponsoring clinical trial NCT00827866?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00827866's enrollment target sits among peer trials
946 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06087224 · 947 participants · NA
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
- NCT05020236 · 944 participants · Phase 3
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- NCT04895709 · 949 participants · Phase 1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia